Compounds, pharmaceutical compositions, and methods of using such compounds to treat or prevent diseases or disorders associated with or mediated by JAMM proteins are disclosed. The compounds and compositions inhibit the enzymatic activity of a JAMM domain, including the JAMM domain of the CSN5 subunit of the COP9-signalsome (CSN), the JAMM domain of the Rpn11/Poh1/Psmd14 subunit of the 26S proteasome, the JAMM domain of AMSH, the JAMM domain of AMSH-LP, the JAMM domain of BRCC36, among other JAMM domains.
本文介绍了化合物、药物组合物以及使用这些化合物治疗或预防与JA
MM蛋白相关或介导的疾病或障碍的方法。这些化合物和组合物抑制JA
MM域的酶活性,包括
COP9信号体(CSN)的CSN5亚基的JA
MM域、26S
蛋白酶的Rpn11/Poh1/Psmd14亚基的JA
MM域、
AMSH的JA
MM域、
AMSH-LP的JA
MM域、BRCC36的JA
MM域等其他JA
MM域。